ArticleJournal of Korean medical science2023

Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study.

Bokyung Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.